Darren S. Cline
Director · PLIANT THERAPEUTICS, INC.
- 2026
- Jun 12, 2026
- 3
Summary
Latest filing:
Darren S. Cline is Director of PLIANT THERAPEUTICS, INC. (PLRX). 3 SEC Form 4 filings on record, most recently on 12 June 2026.
Trading pattern
InsiderAlpha's records for Darren S. Cline go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Darren S. Cline files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Mortimer - $21.42M in XENE purchases and sales in the last 12 months
- Christopher John Kenney - $670K in XENE purchases and sales in the last 12 months
- Steven Gannon - $641K in XENE purchases and sales in the last 12 months
- Thomas Patrick Kelly - $560K in XENE purchases and sales in the last 12 months
- Andrea Difabio - $231K in XENE purchases and sales in the last 12 months
- Bernard Coulie - $114K in PLRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Darren S. Cline?
Darren S. Cline is a corporate insider, tracked as Director of PLIANT THERAPEUTICS, INC. (PLRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Darren S. Cline last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 3 filings going back to 2026.